Rankia USA Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia España Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14,408 / 16,979
#115258

Re: Farmas USA

jejeje y hasta mi chicharrito competidor de AMRN viene premiao ....ACST  1.30 usd, + 23 % en pre ,... eso es 0.38 % para mi que tengo de media 0.94 con una bonita carga ....y me planteo salir pero esperare el  CC de hoy 1.00 pm ,EST...

                                                                --Leerink upgrades .....

Baxter International (NYSE: BAX) initiated with Sector Weight rating at KeyBanc.

Kadmon Holdings (NYSE: KDMN) initiated with Outperform rating and $6 (264% upside) price target at Oppenheimer.

Matinas BioPharma Holdings (NYSEMKT: MTNB) initiated with Buy rating and $4 (398% upside) pride target at H.C. Wainwright.

Acasti Pharma (NASDAQ: ACST) initiated with Buy rating and $6 (471% upside) price target at H.C. Wainwright. Shares up 7% premarket.

Rubius Therapeutics (NASDAQ: RUBY) initiated with Buy rating and $40 (174% upside) price target at H.C. Wainwright.

Denali Therapeutics (NASDAQ: DNLI) initiated with Buy rating and $28 (39% upside) price target at H.C. Wainwright.

Eiger BioPharmaceuticals (NASDAQ: EIGR) initiated with Buy rating and $22 (105% upside) price target at Citigroup.

Titan Pharmaceuticals (NASDAQ: TTNP) initiated with Buy rating and $4 (178% upside) price target at Maxim Group.

AbbVie (NYSE: ABBV) upgraded to Outperform with an $88 (40% upside) price target at SVB Leerink. Shares up 1% premarket.

https://seekingalpha.com/news/3473818-leerink-upgrades-abbvie-premarket-analyst-action?app=1#email_link

Edito. Bueno cuidado ,ya han liberado su Sec Fiiling  FORM 20-F avisando que van a necesitar cash 

#115259

Re: Farmas USA

What To Do With Allergan After AbbVie Bid

Summary

AbbVie is bidding ~$188 (looks a little lower, given the AbbVie drop) per share for Allergan.

$120 per share comes in cash, and the deal should close early 2020.

I've liked Allergan even pre-deal, but market skepticism seems overdone.

Both acquirer and target trade at fairly modest free cash flow multiples as pharma is currently out of favor

https://seekingalpha.com/article/4272096-allergan-abbvie-bid?li_source=LI&li_medium=liftigniter-widget

#115260

Re: Farmas USA

ITCI

Vendido putt 10. Julio, son mensuales.

A ver dónde nos lleva,,,,,

Si te sientas en la mesa y no descubres al "primo" es que lo eres tú.

#115262

Re: Farmas USA

ACST 

Fuera de mi chicharro a 1.25 con + 31 % de profits  despues de 3 meses de espera y recupero mis fuertes perdidas de SRRA mi onco-chicharro anterior 

#115263

Re: Farmas USA

pues si..

gusta

Te puede interesar...

- No hay entradas a destacar -

- No hay entradas a destacar -

Brokers destacados